PDCD1 and neoplasm: Targeting PD-1 or PD-L1 genes, a number of microRNAs have been found to inhibit tumor growth, initiate PD-1 specific T lymphocyte apoptosis, and reverse chemoresistance by blocking PD-1 immune checkpoint [72, 73].